Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir

Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir

Abstract Background Human herpes virus 8 (HHV8) is the causative agent of Kaposi’s sarcoma and has been associated with an increasing number of hematologic diseases such as primary effusion lymphoma (PEL) (both classic and extracavitary form), multicentric Castleman disease and the germinotropic lym...

Full description

Bibliographic Details
Main Authors: Laura Campogiani, Carlotta Cerva, Gaetano Maffongelli, Elisabetta Teti, Livio Pupo, Sara Vaccarini, Maria Cantonetti, Alfredo Pennica, Massimo Andreoni, Loredana Sarmati
Format: Article
Language:English
Published: BMC 2019-07-01
Series:AIDS Research and Therapy
Subjects:
HHV8
Primary effusion lymphoma
Dolutegravir
Online Access:http://link.springer.com/article/10.1186/s12981-019-0230-6

Internet

http://link.springer.com/article/10.1186/s12981-019-0230-6

Similar Items